Baudax Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Baudax Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2022.
  • Baudax Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $20.8M, a 66.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $20.8M +$8.29M +66.4% Dec 31, 2022 8-K 2023-06-28
Q4 2021 $12.5M -$17.2M -58% Dec 31, 2021 8-K 2023-06-28
Q4 2020 $29.7M +$15.6M +111% Dec 31, 2020 10-K 2022-03-16
Q4 2019 $14.1M -$26.5M -65.3% Dec 31, 2019 10-K 2021-02-16
Q4 2018 $40.6M Dec 31, 2018 10-K 2020-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.